切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2023, Vol. 12 ›› Issue (03) : 289 -293. doi: 10.3877/cma.j.issn.2095-3232.2023.03.008

所属专题: 临床研究

临床研究

术前血小板与淋巴细胞比值对肝切除术后肝衰竭的预测价值
夏普开提·甫拉提1, 吐尔洪江·吐逊1, 温浩1,(), 姚刚1   
  1. 1. 830054 乌鲁木齐,新疆医科大学第一附属医院消化血管外科中心 肝脏·腹腔镜外科
  • 收稿日期:2023-01-16 出版日期:2023-06-10
  • 通信作者: 温浩
  • 基金资助:
    国家自然科学基金(82270632); 省部共建中亚高发病成因与防治国家重点实验室包虫病专项(SKL-HIDCA-2020-BC4)

Predictive value of preoperative platelet-to-lymphocyte ratio for post-hepatectomy liver failure

Fulati Xiapukaiti·1, Tuxun Tuerhongjiang·1, Hao Wen1,(), Gang Yao1   

  1. 1. Department of Liver and Laparoscopic Surgery, Digestive Vascular Surgery Center, the First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
  • Received:2023-01-16 Published:2023-06-10
  • Corresponding author: Hao Wen
引用本文:

夏普开提·甫拉提, 吐尔洪江·吐逊, 温浩, 姚刚. 术前血小板与淋巴细胞比值对肝切除术后肝衰竭的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 289-293.

Fulati Xiapukaiti·, Tuxun Tuerhongjiang·, Hao Wen, Gang Yao. Predictive value of preoperative platelet-to-lymphocyte ratio for post-hepatectomy liver failure[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(03): 289-293.

目的

探讨术前血小板与淋巴细胞比值(PLR)对肝切除术后肝衰竭(PHLF)的预测价值。

方法

回顾性分析2014年1月至2019年5月在新疆医科大学第一附属医院行肝切除术的297例患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男157例,女140例;年龄10~76岁,中位年龄43岁。根据是否发生PHLF,将患者分为PHLF组(43例)与非PHLF组(254例)。PHLF发生影响因素的单因素分析采用t检验、秩和检验或χ2检验,多因素分析采用Logistic回归分析。采用ROC曲线分析评估术前PLR水平对PHLF的预测价值。

结果

单因素分析显示,PHLF发生与患者手术方式、肝切除范围、HBV感染、合并腹腔积液密切相关(χ2=12.181,9.413,3.565,12.125;P<0.10),与手术时间、术中出血量、INR、PLR亦相关(Z=3.847,5.211,2.561,-3.452;P<0.10)。多因素Logistic回归分析显示,PLR、手术时间、合并腹腔积液为PHLF的独立危险因素(OR=0.975,1.003,3.154;P<0.05)。PLR预测PHLF的ROC曲线下面积为0.665(95%CI:0.597~0.733),PLR最佳截断值为161,敏感度和特异度分别为1.000和0.594。终末期肝病模型(MELD)评分对PHLF预测的曲线下面积为0.612,与PLR比较差异无统计学意义(Z=2.352,P>0.05)。

结论

术前PLR可作为评估PHLF的临床指标,具有良好的预测效能,敏感度较高,可达到MELD评分相同的预测价值。

Objective

To evaluate the predictive value of preoperative platelet-to-lymphocyte ratio (PLR) for post-hepatectomy liver failure (PHLF).

Methods

Clinical data of 297 patients who underwent hepatectomy in the First Affiliated Hospital of Xinjiang Medical University from January 2014 to May 2019 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 157 patients were male and 140 female, aged from 10 to 76 years, with a median age of 43 years. According to the incidence of PHLF, all patients were divided into the PHLF (n=43) and non-PHLF groups (n=254). Univariate analysis of influencing factors of PHLF was conducted by t test, rank-sum test or Chi-square test. Multivariate analysis was performed by Logistic regression analysis. The predictive value of preoperative PLR for PHLF was evaluated by the receiver operating characteristic (ROC) curve analysis.

Results

Univariate analysis showed that the incidence of PHLF was correlated with the operative procedure, range of hepatectomy, HBV infection and ascites (χ2=12.181, 9.413, 3.565, 12.125; P<0.10), which was also correlated with the operation time, intraoperative blood loss, INR and PLR (Z=3.847, 5.211, 2.561, -3.452; P<0.10). Multivariate Logistic regression analysis revealed that PLR, operation time and ascites were the independent risk factors for PHLF (OR=0.975, 1.003, 3.154; P<0.05). The area under ROC curve (AUC) of PLR for predicting PHLF was 0.665 (95%CI: 0.597-0.733), the optimal cutoff value of PLR was 161, and the sensitivity and specificity were 1.000 and 0.594. The AUC of Model for End-stage Liver Disease (MELD) score for predicting PHLF was 0.612, and there was no significant difference compared with PLR (Z=2.352, P>0.05).

Conclusions

Preoperative PLR can be used as a clinical index to evaluate PHLF. It yields high predictive efficiency and high sensitivity, which can achieve equivalent predictive value as MELD score.

表1 PHLF发生与肝切除术患者临床指标的关系
表2 PHLF发生与肝切除术患者术前实验室指标的关系[MQR)]
表3 PHLF发生的多因素Logistic回归分析
图1 术前PLR对PHLF预测的ROC曲线注:PHLF为肝切除术后肝衰竭,PLR为血小板与淋巴细胞比值
表4 不同因素对PHLF的预测价值
[1]
董家鸿, 叶晟. 开启精准肝胆外科的新时代[J/CD]. 中华普外科手术学杂志(电子版), 2016, 10(3):181-184.
[2]
陈佳佳, 范林骁, 李兰娟.《肝衰竭诊治指南(2018版)》指南解读[J]. 中国临床医生杂志, 2020, 48(11):1279-1282.
[3]
Guglielmi A, Ruzzenente A, Conci S, et al. How much remnant is enough in liver resection[J]. Dig Surg, 2012, 29(1):6-17.
[4]
Balzan S, Belghiti J, Farges O, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy[J]. Ann Surg, 2005, 242(6):824-828.
[5]
Mullen JT, Ribero D, Reddy SK, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy[J]. J Am Coll Surg, 2007, 204(5):854-862.
[6]
Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS)[J]. Surgery, 2011, 149(5):713-724.
[7]
Starlinger P, Haegele S, Offensperger F, et al. The profile of platelet α-granule released molecules affects postoperative liver regeneration[J]. Hepatology, 201663(5):1675-1688.
[8]
王改平, 李晓芳, 陈莎莎, 等. 肝脏炎症反应与肝再生关系的研究进展[J]. 中国免疫学杂志, 2015, 31(8):1115-1119.
[9]
Li S, Tian G, Chen Z, et al. Prognostic role of the prognostic nutritional index in pancreatic cancer: a meta-analysis[J]. Nutr Cancer, 2019, 71(2):207-213.
[10]
Ma W, Zhang P, Qi J, et al. Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis[J]. Sci Rep, 2016, 14(6):35378.
[11]
Fan X, Chen G, Li Y, et al. The preoperative prognostic nutritional index in hepatocellular carcinoma after curative hepatectomy: a retrospective cohort study and meta-analysis[J]. J Invest Surg, 2021, 34(8):826-833.
[12]
Wang YPeng CCheng Z,et al. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: a systematic review and meta-analysis[J]. Int J Surg, 2018(55):73-80.
[13]
朱鹏, 张志伟. 肝脏解剖和肝切除手术命名及肝切除术中控制出血方法和选择原则(2017年第1次修订,第2版)[J]. 腹部外科, 2017, 30(2):75-78.
[14]
Alizai PH, Haelsig A, Bruners P, et al. Impact of liver volume and liver function on posthepatectomy liver failure after portal veinembolization-a multivariable cohort analysis[J]. Ann Med Surg, 2017(25):6-11.
[15]
Lisman T, Porte RJ. Mechanisms of platelet-mediated liver regeneration[J]. Blood, 2016, 128(5):625-629.
[16]
van den Broek MA, Olde Damink SW, Dejong CH, et al. Liver failure after partial hepatic resection: definition, pathophysiology, risk factors and treatment[J]. Liver Int, 2008, 28(6):767-780.
[17]
Hyder O, Pulitano C, Firoozmand A, et al. A risk model to predict 90-day mortality among patients undergoing hepatic resection[J].J Am Coll Surg, 2013, 216(6):1049-1056.
[18]
Rahbari NN, Reissfelder C, Koch M, et al. The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients[J]. Ann Surg Oncol, 2011, 18(13):3640-3649.
[19]
冯晴, 方吉, 陈雪丹. 术前炎症指标对肝细胞癌肝切除术患者的预后预测价值[J]. 中国癌症防治杂志, 2021, 13(5):529-533.
[20]
金建国, 曹晓, 胡冰冰. NLR、PLR对肝硬化肝癌患者预后的预测价值分析[J]. 实用癌症杂志, 2020, 35(1):62-65.
[21]
王晓晶, 张小平, 宁琴. 肝衰竭的免疫发病机制[J]. 临床肝胆病杂志, 2014, 30(10):984-991.
[1] 钟锴, 蒋铁民, 张瑞青, 吐尔干艾力·阿吉, 邵英梅, 郭强. 加速康复外科在肝囊型棘球蚴病肝切除术中的应用分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 425-429.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[4] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[5] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[6] 胡森焱, 徐冬, 方健, 谢冬冬, 王财庆. ICG荧光显影Laennec膜入路腹腔镜解剖性肝切除的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 513-516.
[7] 林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[8] 曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[9] 张金华, 赵锁. 早期ICC腹腔镜肝切除术不同淋巴结清扫范围的近远期效果对比研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 578-581.
[10] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
[11] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[12] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[13] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[14] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[15] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
阅读次数
全文


摘要